Search

February 2002—This Statement gives the revised NBG code, endorsed by the British Pacing and Electrophysiology Group (BPEG) and the North American Society of Pacing and Electrophysiology (NASPE, now known as Heart Rhythm Society) in 2001. This statement is more compatible with contemporary and emerging pacing technology with particular attention to the issue of multisite pacing.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.

August 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be lifesaving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

This document was reaffirmed on April 11, 2018, and will be formally assessed by April 2023.

July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.

This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2021.

May 17, 2010—This document was developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). It focuses on patients nearing the end of life and addresses patients who have made a decision for CIED deactivation at other times, as well as the rights and responsibilities of clinicians (and others, such as industry-employed allied professionals) who may not wish to perform deactivation.

This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2023.

March 20, 2006—Following the recall event in 2005, the Guidant Corporation commissioned an independent panel charged with studying, analyzing, and evaluating the policies and procedure of the cardiac rhythm management (CRM) business with regard to postmarket device surveillance. This report summarizes the findings and recommendations of the panel.

This document has been retired because it is no longer current.

July 2003—This statement provides additional information regarding maintenance of skills related to device implantation, more detailed training guidelines for CIED implantation and lead extraction, and initial guidelines for implantation of cardiac resynchronization devices that require additional leads to be placed at alternative pacing sites.

This document has been retired because it is no longer current.

June 2002—Based on the Consensus Conference held during the 21st Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology (NASPE; now known as the Heart Rhythm Society), this consensus statement covers issues of specific cardiac arrhythmias in children with or without congenital heart disease (CHD), the special needs of children and patients with CHD, and how best to meet these needs.

This document has been retired and replaced by 2016 “PACES/HRS Expert Consensus Statement on the Use of Catheter Ablation in Children and Patients with Congenital Heart Disease.”

Today, the Heart Rhythm Society (HRS) released communication recommendations to assist health care professionals to understand and prepare for potential cybersecurity vulnerabilities of cardiovascular implantable electronic devices (CIEDs). The proceedings statement outlines four key communication themes: when to notify patients, whom to notify, how to communicate with patients, and what elements to discuss with patients. The statement will be presented on Thursday, May 10, at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.